Journalists

A phase 2 clinical trial has analysed the safety and efficacy of adding immunotherapy to traditional chemotherapy to treat a subtype of acute lymphoblastic leukaemia in children under one year of age. This subtype of leukaemia, although rare in absolute terms, is the most common in children of this age, and its prognosis in this age group had not improved in recent years. The immunotherapy used, a bispecific antibody that binds to tumour cells on the one hand and T lymphocytes on the other, improved two-year survival from 66% to 93% in treated patients, according to The New England Journal of Medicine (NEJM).

The current situation is only the beginning of what may come in the coming decades, which should lead us to increase efforts in mitigation and adaptation strategies: more green and shaded areas, energy efficiency in buildings and avoiding working outdoors in extreme temperatures.

The State Meteorological Agency (AEMET) has reported that, from Tuesday, the progressive entry of a mass of very warm and dry air of African origin over the peninsula and the Balearic Islands will cause exceptionally high temperatures for this time of year, with values typical of summer. According to AEMET, during Thursday 27, the threshold of 30 ºC is likely to be exceeded throughout the southern half, as well as on the banks of the Ebro. On the other hand, 35 ºC is likely to extend to the Guadalquivir valley in Córdoba and Jaén. During Friday it is possible that 35 ºC will be exceeded in the banks of the Ebro in Zaragoza and other points of the southern half, in addition to the Guadalquivir valley, where the maximum temperature values could be around 38-40 ºC.

Faecal microbiota transplantation can be administered by oral capsules, colonoscopy or rectal enema, among other routes. Two meta-analyses evaluate its benefits and side effects for treating two types of disease. The first focuses on recurrent infections with Clostridioides difficile, a bacterium that can cause very severe diarrhoea; it includes six studies in Europe and North America involving 320 adults and concludes that in immunocompetent people, faecal transplantation is more effective than antibiotics. The second focuses on irritable bowel diseases, such as ulcerative colitis and Crohn's disease; it includes 12 studies with 550 participants and has less clear results.

Species of birds common in the marshes of Doñana as the common tern, the brown pochard, the marbled teal, the marsh harrier or the black-bellied sandpiper have recorded a decline in their population for more than a decade, a trend that accelerated since 2019. This is one of the conclusions of the Report on the conservation status of waterfowl in Doñana, published today by SEO/BirdLife.

A drug in gel form cured 100 percent of mice with a very aggressive brain tumor. The authors hope that this is a first step towards helping human patients with glioblastoma, one of the most dangerous brain tumors in humans. The article is published today in PNAS.

A study of 89 patients has shown that the drug teriflunomide is able to delay the onset of multiple sclerosis symptoms in people whose MRI scans show early signs of the disease, even if they have not yet developed symptoms. The work has not yet been published in a scientific journal and its results have been shared at a meeting of the American Neurological Association.

A study led by Spanish researchers and published in Science Advances has tested a new technique to improve gene therapy treatments for Parkinson's disease. Using ultrasound, they have managed to open the blood-brain barrier in specific areas, allowing the viruses used in the therapy to pass through and better reach the desired brain areas. After testing it on monkeys and three patients -patients were not given gene therapy, but the efficacy of the technique was tested using a radiotracer that does not normally cross the blood-brain barrier-, their conclusions are that the technique is safe and feasible and "could allow early and frequent interventions to treat neurodegenerative diseases".

A study published in the journal Science Translational Medicine shows the results of a phase 1 trial of a new broad-spectrum influenza vaccine. Prepared in the form of nanoparticles containing the H1 hemagglutinin stem-a region that is often conserved in different subtypes of the virus-the vaccine was generally well tolerated by participants, who showed only mild side effects such as tenderness and headaches. The prototype generated an antibody response to group 1 influenza viruses in all age groups.

A research team including scientists from the University of Santiago de Compostela and the Centro Tecnológico Agroalimentario de Lugo has analysed the presence of potentially pathogenic bacteria in 100 meat samples bought in supermarkets in Oviedo, Spain in 2020. The researchers found E. coli bacteria which produce enzymes that make the bacteria resistant to various types of antibiotics in more than half of the turkey (68 %) and chicken (56 %) samples, and less frequently in beef (16 %) and pork (12 %) samples. They also found E. coli bacteria that can cause urinary tract infections. The team presented these results at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), which is being held in Copenhagen, Denmark, until 18 April.